Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Psychedelics

Connecticut Could Soon Expand Psychedelic Pilot Program

Previously limited to veterans and other specific populations, the bill could apply to any adult that meets clinical eligibility criteria.

Read More →

May 18, 2026

Louisiana Considers Psychedelic-Assisted Therapy Program

Psilocybin and ibogaine clinical trials would target opioid use disorder and treatment-resistant mental health conditions.

Read More →

May 18, 2026

Mental Health Psychedelics

Minnesota Considers Psychedelics Therapy Program

A three-year pilot program would allow for 1,000 patients annually to receive treatment for PTSD, depression, chronic pain, and more.

Read More →

May 18, 2026

Claim Costs Claim Data

NCCI Publishes 2026 State of the Line Report

While claim frequency is declining, severity is increasing, with injured workers receiving more care or more complex treatment.

Read More →

May 18, 2026

Billing & Payments Claims Procedures

Washington Increases Penalties for Violations of Workers’ Comp Laws

Effective July 1st, certain violations of workers’ comp law will see a 12.11% increase in penalties.

Read More →

May 18, 2026

Billing & Payments

Department of Labor Expands Pharmacy Models Across Programs

This development signals a shift toward a standardized OWCP pharmacy model that could impact Longshore and Black Lung claimants.

Read More →

May 11, 2026

Worker Classification

New York Could Cover 9/11 Claims for National Guard Responders

If enacted, the bill would categorize organized militia members as state employees, entitling them to workers’ comp benefits.

Read More →

May 11, 2026

Worker Classification

Ohio Bill Could Entitle Rideshare Drivers to Workers’ Comp

If enacted, rideshare companies would have to report drive-time data quarterly that would determine workers’ comp premiums.

Read More →

May 11, 2026

Access to Care

WCRI Reports on Impact of Hospital Closures on Access to Care and Claims Outcomes

While patients in rural areas had to travel further for care, there were no meaningful increases to claim costs or disability duration.

Read More →

May 11, 2026

« Previous 1 2 3 4 5 6 … 56 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

States Seek to Limit AI-Generated Care Decisions, Despite White House Order

Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.

Could AI-Designed Drugs Impact Regulatory Frameworks?

While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.